21-U.S.C.-379DD-2

21-U.S.C.-379DD-2

§379Dd-2 – §379Dd-2. Activities of The Food and Drug Administration

Pathway

Title 21 > Chapter 9 > Subchapter VII > Part I > Section 379dd-2

Details

  • Reference: Section 379dd-2
  • Legend: §379Dd-2 – §379Dd-2. Activities of The Food and Drug Administration
  • USCode Year: 2013

Provision Content

(a) In general

The Commissioner shall receive and assess the report submitted to the Commissioner by the Executive Director of the Foundation under section 379dd(l)(2) of this title.

(b) Report to Congress

Beginning with fiscal year 2009, the Commissioner shall submit to Congress an annual report summarizing the incorporation of the information provided by the Foundation in the report described under section 379dd(l)(2) of this title and by other recipients of grants, contracts, memoranda of understanding, or cooperative agreements into regulatory and product review activities of the Food and Drug Administration.

(c) Extramural grants

The provisions of this part and section 360bbb–5 of this title shall have no effect on any grant, contract, memorandum of understanding, or cooperative agreement between the Food and Drug Administration and any other entity entered into before, on, or after September 27, 2007.

(June 25, 1938, ch. 675, §772, as added Pub. L. 110–85, title VI, §601(b), Sept. 27, 2007, 121 Stat. 897.)

U.S. Encyclopedia of Law Coverage

21-U.S.C.-379J-53 in the Legal Encyclopedia: Drugs General Authority

In this entry about 21-U.S.C.-379J-53, find legal reference material, bibliographies and premiere content related to drugs general authority in the American Encyclopedia of Law, presenting a comprehensive view of the United States drugs general authority-specific issues, written by authorities in the field.

Topic Map


Posted

in

by

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *